HT&E Ltd
ASX:HT1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HT&E Ltd
ASX:HT1
|
AU |
|
Codelab Capital AS
F:P99
|
NO |
|
P
|
Porvair PLC
LSE:PRV
|
UK |
|
M
|
Monnari Trade SA
WSE:MON
|
PL |
|
S
|
Savencia SA
F:BGJ
|
FR |
|
Invex Therapeutics Ltd
ASX:IXC
|
AU |
|
Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
|
CN |
|
Silverline Endustri ve Ticaret AS
IST:SILVR.E
|
TR |
|
Patria Investments Ltd
NASDAQ:PAX
|
KY |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HT1's stock price target?
Not Available
HT1 doesn't have any price targets made by Wall Street professionals.
What is HT&E Ltd's Revenue forecast?
Projected CAGR
-18%
For the last 1 year the
compound annual growth rate for
HT&E Ltd's revenue is
53%.
The projected
CAGR
for the next 2 years is
-18%.